Asinex

Since 1994, Asinex has provided screening libraries of lead-like molecules, research reagents and building blocks that have greatly enhanced the medicinal chemistry programs of our clients throughout the world. Asinex can respond efficiently to the demands of our industrial and academic partners through collaborative engagement in many disciplines, including medicinal chemistry and early drug design and biology services.

With over 20 years of research experience, Asinex facilitates the discovery of novel modulators of pharmacologically-relevant “difficult” targets and signaling pathways primarily focusing on protein-protein interactions, functional, noncoding RNAs and cancer metabolism.